Africa Open Lab is a grant from GSK that funds early-career African scientists conducting innovative research on infectious diseases. The program supports population-based or clinical studies addressing malaria, tuberculosis, drug-resistant bacterial infections, and enteric infections, with a focus on epidemiology, prevention, treatment compliance, antimicrobial resistance, and health policy impact. Funded projects may include clinical or field sample analysis; purely in vitro or animal-model studies are not eligible. Eligible applicants are African scientists at an early stage of their research careers with an interest in infectious disease. Full proposals are due by August 14, 2026, following a concept proposal review stage.

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.